Form D · Pharmaceuticals
AGIOS PHARMACEUTICALS INC
Cambridge, MA · CIK 0001439222
Offering snapshot reported Nov 22, 2011 · SEC filing
- Reported sold
- $78M Offering amount: $78M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 16, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 22, 2011 | Initial | $78,000,001 | No comparison | 19 | SEC filing |
| Apr 26, 2010 | Initial | $8,823,937 | No comparison | 1 | SEC filing |
| Jul 1, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-169115
Source: Form D, filed Nov 22, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lewis C. Cantley | Director |
| Doug Cole | Director |
| Duncan Higgons | Executive |
| Perry Karsen | Director |
| John Maraganore | Director |
| Robert Nelsen | Director |
| David Schenkein | Director, Executive |
| Kevin Starr | Director |
| Marc Tessier Lavigne | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
38 Sidney Street 2nd Floor
Cambridge, MA, 02139
Cambridge, MA, 02139